- Home
- SXT vs EWTX Comparison
SXT vs EWTX Comparison
Compare SXT & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXT
- EWTX
- Stock Information
- Founded
- SXT 1882
- EWTX 2017
- Country
- SXT United States
- EWTX United States
- Employees
- SXT N/A
- EWTX N/A
- Industry
- SXT Major Chemicals
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- SXT Industrials
- EWTX Health Care
- Exchange
- SXT Nasdaq
- EWTX Nasdaq
- Market Cap
- SXT 2.9B
- EWTX 2.7B
- IPO Year
- SXT N/A
- EWTX 2021
- Fundamental
- Price
- SXT $69.22
- EWTX $27.07
- Analyst Decision
- SXT Buy
- EWTX Buy
- Analyst Count
- SXT 1
- EWTX 7
- Target Price
- SXT $85.00
- EWTX $42.71
- AVG Volume (30 Days)
- SXT 189.4K
- EWTX 950.6K
- Earning Date
- SXT 02-14-2025
- EWTX 02-28-2025
- Dividend Yield
- SXT 2.37%
- EWTX N/A
- EPS Growth
- SXT 33.03
- EWTX N/A
- EPS
- SXT 2.94
- EWTX N/A
- Revenue
- SXT $1,557,228,000.00
- EWTX N/A
- Revenue This Year
- SXT $4.48
- EWTX N/A
- Revenue Next Year
- SXT $4.24
- EWTX N/A
- P/E Ratio
- SXT $23.55
- EWTX N/A
- Revenue Growth
- SXT 6.92
- EWTX N/A
- 52 Week Low
- SXT $64.11
- EWTX $14.90
- 52 Week High
- SXT $82.99
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- SXT 33.78
- EWTX 48.74
- Support Level
- SXT $68.78
- EWTX $24.92
- Resistance Level
- SXT $70.72
- EWTX $29.14
- Average True Range (ATR)
- SXT 1.69
- EWTX 1.64
- MACD
- SXT -0.85
- EWTX 0.01
- Stochastic Oscillator
- SXT 16.18
- EWTX 38.67
About SXT Sensient Technologies Corporation
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.